U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory precursor T-lymphoblastic lymphoma/leukemia

MedGen UID:
167728
•Concept ID:
C0854859
•
Neoplastic Process
Synonyms: Precursor T Lymphoblastic Lymphoma/Leukemia Refractory; precursor T lymphoblastic lymphoma/leukemia refractory; Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia; refractory precursor T-lymphoblastic lymphoma/leukemia; Refractory T Lymphoblastic Leukemia/Lymphoma; refractory T lymphoblastic leukemia/lymphoma; Refractory T-Lymphoblastic Leukemia/Lymphoma
 
Monarch Initiative: MONDO:0004404

Definition

T-lymphoblastic leukemia/lymphoma that is resistant to treatment [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRefractory precursor T-lymphoblastic lymphoma/leukemia

Recent clinical studies

Etiology

Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L
Leuk Lymphoma 2020 Apr;61(4):855-861. Epub 2019 Nov 22 doi: 10.1080/10428194.2019.1691195. PMID: 31755348

Diagnosis

T-Lymphoblastic Leukemia/Lymphoma and Thymoma: A Case Report and Review of the Literature of a Rare Association.
Mizrahi N, Kugler E, Hayman L, Yeshurun M, Grossman A, Raanani P, Wolach O
Acta Haematol 2022;145(1):106-111. Epub 2021 Sep 17 doi: 10.1159/000519033. PMID: 34537764

Therapy

Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L
Leuk Lymphoma 2020 Apr;61(4):855-861. Epub 2019 Nov 22 doi: 10.1080/10428194.2019.1691195. PMID: 31755348

Prognosis

T-Lymphoblastic Leukemia/Lymphoma and Thymoma: A Case Report and Review of the Literature of a Rare Association.
Mizrahi N, Kugler E, Hayman L, Yeshurun M, Grossman A, Raanani P, Wolach O
Acta Haematol 2022;145(1):106-111. Epub 2021 Sep 17 doi: 10.1159/000519033. PMID: 34537764
Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L
Leuk Lymphoma 2020 Apr;61(4):855-861. Epub 2019 Nov 22 doi: 10.1080/10428194.2019.1691195. PMID: 31755348

Clinical prediction guides

Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L
Leuk Lymphoma 2020 Apr;61(4):855-861. Epub 2019 Nov 22 doi: 10.1080/10428194.2019.1691195. PMID: 31755348

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...